Polymorphism of interleukin-1β affects the eradication rates of Helicobacter pylori by triple therapy
- 31 January 2004
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 2 (1), 22-30
- https://doi.org/10.1016/s1542-3565(03)00288-x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase CGut, 2001
- Interleukin 1 Polymorphisms, Lifestyle Factors, andHelicobacter pyloriInfectionJapanese Journal of Cancer Research, 2001
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- STIMULATION OF IL-8 PRODUCTION IN HUMAN GASTRIC EPITHELIAL CELLS BYHELICOBACTER PYLORI, IL-1β AND TNF-α REQUIRES TYROSINE KINASE ACTIVITY, BUT NOT PROTEIN KINASE CCytokine, 1997
- Pharmacokinetics, Metabolism and Interactions of Acid Pump InhibitorsClinical Pharmacokinetics, 1996
- Expression of Cytokine mRNA in Gastric Mucosa withHelicobacter pyloriInfectionScandinavian Journal of Gastroenterology, 1995
- Interethnic Differences in Omeprazole Metabolism in the Two S-Mephenytoin Hydroxylation Phenotypes Studied in Caucasians and OrientalsTherapeutic Drug Monitoring, 1994
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993
- Evaluation of a new selective medium forCampylobacter pyloriEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988